Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Morris

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cell|December 25, 2018
p53 Represses the Mevalonate Pathway to Mediate Tumor SuppressionSung-Hwan Moon, Chun-Hao Huang, Shauna L Houlihan, et al.
Cell|April 16, 2026
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transitionJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Cancer Research|February 11, 2025
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic CancerJonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker, et al.
Research Square|December 3, 2025
Small Molecule Activators of the Mitochondrial Protease ClpP Induce Senescence in Triple-Negative Breast Cancer Cells and Sensitize Cells to the Bcl-2 Inhibitor VenetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Nature|August 17, 2022
Ordered and deterministic cancer genome evolution after p53 lossTimour Baslan, John P Morris, Zhen Zhao, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Cancer Cell|June 20, 2020
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic CancerLuisa F Escobar-Hoyos, Alex Penson, Ram Kannan, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cell|December 25, 2018
p53 Represses the Mevalonate Pathway to Mediate Tumor SuppressionSung-Hwan Moon, Chun-Hao Huang, Shauna L Houlihan, et al.
Cell|April 16, 2026
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transitionJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Cancer Research|February 11, 2025
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic CancerJonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker, et al.
Research Square|December 3, 2025
Small Molecule Activators of the Mitochondrial Protease ClpP Induce Senescence in Triple-Negative Breast Cancer Cells and Sensitize Cells to the Bcl-2 Inhibitor VenetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Nature|August 17, 2022
Ordered and deterministic cancer genome evolution after p53 lossTimour Baslan, John P Morris, Zhen Zhao, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Cancer Cell|June 20, 2020
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic CancerLuisa F Escobar-Hoyos, Alex Penson, Ram Kannan, et al.
Pageof 5